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Nowadays, the emergence of multidrug resistant bacteria requires interest in the medical field and thereby an urgent need to develop efficient
and specific methods in targeting unique bacterial cellular processes.1,2 Two-component signal transduction systems (TCS) are widely used in
bacteria to allow adaptation, osmosis and resistance appearance by translating an external signal into a cellular response. In order to attenuate
these signaling pathways, we aimed at targeting the TCS signal transducer histidine kinase by focusing on their highly conserved ATP-binding
domain.3 Preliminary modeling work carried out in our laboratory led to a series of thiophene derivatives. Twenty-one new thiophene derivatives
were synthesized and evaluated in vitro on bacterial histidine kinases (HK) PhoR, ResE and WalK, from which eight derivatives showed
significant inhibitory activity. One compound exhibited broad-spectrum antimicrobial activity with the particularity to restore antibacterial activity
of antibiotics ineffective on resistant bacteria treated alone,4 With the purpose to improve biological activity, amino thiophene derivatives have
been developed.
In this work, we have designed and synthesized a series of 24 molecules with thiophene and furane ring by Suzuki-Miyaura coupling. On the
other hand, two hydrochloride salts of nitrothiophene derivatives were synthesized to increase solubility, stability and therefore biodisponibility.
All compounds were characterized by 1H and 13C NMR and analyzed by LC-MS and HRMS. Two of them (6d and 6e) exhibit significant
inhibition of multiple HK and exhibited broad-spectrum antimicrobial activity. Moreover they do not inhibit the others GHKL superfamily
proteins in addition to not hydrolyzing sheep red blood cells. More soluble hydrochloride salts of first designed amines (6a-8c) do not improve
histidine kinase inhibition. The compounds were also evaluated as adjuvant against Escherichia coli extended spectrum β-lactamase (ESBL)
and Methicillin resistant Staphylococcus aureus (MRSA). From this latter, derivative 6d showed adjuvant properties because of its tendency to
restore antibacterial activity in presence of antibiotics on resistant bacteria.
I. INTRODUCTION
IV. CONCLUSION
II. SYNTHESIS III. BIOLOGICAL EVALUATIONS
All the derivatives were characterized by FT-IR, 1H, 13C NMR, UPLC and HRMS.
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Evaluations have been realized on other proteins of the
GHKL (DNA Gyrase, Hsp90, Histidine Kinase, MutL)
superfamily. The 8 potent molecules are:
- Specific towards tested HK (WalK, PhoR and ResE)
- Inactive towards Ser/Thr kinase (IreK)
- Inactive towards DNA gyrase
- No hemolytical activity
Compounds PhoR
(µM)
ResE (µM) WalK (µM) IreK (µM) DNA-
gyrase
(µM)
6d 122.6 124.3 196.9 > 800 > 400
6e 13.11 89.36 52.81 > 800 > 800
11d 50.53 / / / / 
Reduction of the most potent
compounds to experiment SAR
Table 1. IC50 values against histidine kinase PhoR,
ResE and WalK; Ser/Thr kinase IreK and DNA-gyrase
for compounds 6d, 6e and 11d.
6d exhibits adjuvant activity in presence of antibiotics
whereas 6e showed antibacterial activity.
Figure 1: Structures of molecules 6d and 6e.
Scheme 1: Synthesis of thiophene and furanes derivatives.
Scheme 2: Synthesis of hydrochloride salts 11d and 11e.
